Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1-Reference-Cited by-同舟云学术

Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1

Published:2016-03 Issue: Volume:92 Page:100-109
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Choquet Hélène,Trapani Eliana,Goitre Luca,Trabalzini Lorenza^ORCID,Akers Amy,Fontanella Marco^ORCID,Hart Blaine L.,Morrison Leslie A.,Pawlikowska Ludmila,Kim Helen,Retta Saverio Francesco

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference121 articles.

1. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations;Clatterbuck;J. Neurol. Neurosurg. Psychiatry,2001

2. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance;Gault;Neurosurgery,2004

3. Cavernous malformations: natural history, diagnosis and treatment;Batra;Nat. Rev. Neurol.,2009

4. Cerebral cavernous malformations: from genes to proteins to disease;Cavalcanti;J. Neurosurg.,2012

5. Genotype–phenotype correlations in cerebral cavernous malformations patients;Denier;Ann. Neurol.,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variants in FCGR2A, PTPN2, VDR as predictive signatures of aggressive phenotypes in cerebral cavernous malformation;Gene;2025-01

2. Whole-Genome Omics Elucidates the Role of CCM1 and Progesterone in Cerebral Cavernous Malformations within CmPn Networks;Diagnostics;2024-08-28

3. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review;Biochemical Pharmacology;2024-05

4. Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation;Brain Sciences;2023-09-17

5. Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targets;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2023-08